Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study.
<h4>Background</h4>Angiotensin receptor blockers (ARBs) may have protective effects against dementia occurrence in patients with hypertension (HTN). However, whether telmisartan, an ARB with peroxisome proliferator-activated receptor γ (PPAR-γ)-modulating effects, has additional benefits...
Main Authors: | Chi-Hung Liu, Pi-Shan Sung, Yan-Rong Li, Wen-Kuan Huang, Tay-Wey Lee, Chin-Chang Huang, Tsong-Hai Lee, Tien-Hsing Chen, Yi-Chia Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-07-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.1003707 |
Similar Items
-
Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study
by: Chi-Hung Liu, et al.
Published: (2020-01-01) -
The telmisartan and amlodipine combination in the treatment of hypertension
by: G G Shehyan, et al.
Published: (2014-03-01) -
THE EFFECTS NEUROPROTECTION OF TELMISARTAN ON STROKE WITH HYPERTENSION
by: ErnawatI, Iin, et al.
Published: (2020-01-01) -
Telmisartan and Rosuvastatin Synergistically Ameliorate Dementia and Cognitive Impairment in Older Hypertensive Patients With Apolipoprotein E Genotype
by: Wenjing Hu, et al.
Published: (2020-06-01) -
Immune pleiotropic effect of telmisartan in arterial hypertension
by: N. M. Agarkov, et al.
Published: (2022-07-01)